Clinical Trial 46649

Pearland, TX 77584


Summary:

You have been asked to participate in this study because you have Active Ulcerative Colitis (UC). The study drug is a novel (first-in-class small molecule) oral study treatment for UC. NX-13 activates the Nod-like receptor X1; (NLRX1), which may improve the condition of the bowel.


Qualified Participants Must:

• Have diagnosis of UC for 90 days or more prior to screening.
• Other criteria will apply. Details will be provided.


Qualified Participants May Receive:

You will receive up to $100 following each completed study visit.


Available At:

Linq Research

Pearland, TX 77584
View Clinic Location

 


If you or someone you care for is interested in participating and lives within 25 miles of the location shown, please complete the form below and click 'Submit'

Clinical trials are medical research studies designed to test the safety and/or effectiveness of new investigational drugs, devices, or treatments in humans. These studies are conducted worldwide for a range of conditions and illnesses. Learn more about clinical research and participating in a study at About Clinical Trials.